Zvi Ram

Author PubWeight™ 60.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 2003 4.17
2 NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 2012 3.66
3 Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 2007 2.38
4 Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol 2013 2.08
5 Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 2007 2.01
6 Conflicting pathology reports: a diagnostic dilemma. J Neurosurg 2014 1.98
7 MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem Biophys Res Commun 2008 1.85
8 Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 2004 1.78
9 Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 2010 1.78
10 Neurosurgery and pregnancy. Acta Neurochir (Wien) 2011 1.52
11 Multimodal treatment of hemorrhagic pituitary metastasis as first manifestation of renal cell carcinoma. World Neurosurg 2012 1.50
12 Epidemiology of gliomas in Israel: a nationwide study. Neuroepidemiology 2008 1.47
13 The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res 2009 1.39
14 Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 2005 1.35
15 Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004 1.32
16 Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring. Neuro Oncol 2008 1.14
17 Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res 2004 1.11
18 Anterograde and retrograde amnesia in a person with bilateral fornix lesions following removal of a colloid cyst. Neuropsychologia 2006 1.03
19 Treatment of intra-cranial aneurysms with the SILK flow diverter: 2 years' experience with 28 patients at a single center. Acta Neurochir (Wien) 2012 0.98
20 Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model. Neurosurgery 2007 0.96
21 Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 2002 0.96
22 Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles. Int J Nanomedicine 2011 0.93
23 Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med 2014 0.91
24 Intraoperative mapping and monitoring of the corticospinal tracts with neurophysiological assessment and 3-dimensional ultrasonography-based navigation. Clinical article. J Neurosurg 2010 0.90
25 Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 2004 0.89
26 A rapid assay for drug sensitivity of glioblastoma stem cells. Biochem Biophys Res Commun 2007 0.86
27 Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor. J Neurosurg 2012 0.85
28 Management and outcome of non-traumatic cerebellar haemorrhage. Cerebrovasc Dis 2002 0.85
29 Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumors. PLoS One 2012 0.85
30 Prediction of neurological deficits and recovery after surgery in the supplementary motor area: a prospective study in 26 patients. J Neurosurg 2010 0.84
31 Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors. Neurosurgery 2004 0.84
32 The impact of enrollment in clinical trials on survival of patients with glioblastoma. J Clin Neurosci 2012 0.82
33 Gliomas of the posterior fossa in adults. J Neurooncol 2013 0.82
34 The ventricular system and choroid plexus as a primary site for renal cell carcinoma metastasis. Acta Neurochir (Wien) 2014 0.82
35 Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. J Immunol 2011 0.82
36 Language related reorganization in adult brain with slow growing glioma: fMRI prospective case-study. Neurocase 2008 0.81
37 Supratentorial calcified pseudotumour: experience of a single institution and review of the literature. Acta Neurochir (Wien) 2014 0.81
38 Intraoperative seizures during awake craniotomy: incidence and consequences: analysis of 477 patients. Neurosurgery 2013 0.80
39 Intraoperative 5-aminolevulinic acid-induced fluorescence in primary central nervous system lymphoma. J Neurosurg 2013 0.80
40 Surgical therapies in brain metastasis. Semin Oncol 2007 0.80
41 Intrathecal gene therapy for treatment of leptomeningeal carcinomatosis. J Neurooncol 2010 0.79
42 Outcome of elderly patients undergoing awake-craniotomy for tumor resection. Ann Surg Oncol 2012 0.78
43 Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls. J Neurooncol 2011 0.78
44 Optic pathway gliomas in adults. Neurosurgery 2014 0.78
45 Control of postoperative pain after awake craniotomy with local intradermal analgesia and metamizol. Isr Med Assoc J 2007 0.77
46 Tumor location and IDH1 mutation may predict intraoperative seizures during awake craniotomy. J Neurosurg 2014 0.77
47 Reversible freezing of gait caused by dural arteriovenous fistula and congestion of the globus pallidus. Mov Disord 2012 0.77
48 Intracranial infections caused by Actinomyces species. World Neurosurg 2011 0.77
49 The dark side of Nrf2. World Neurosurg 2012 0.77
50 Intractable vomiting from glioblastoma metastatic to the fourth ventricle: three case studies. Neuro Oncol 2002 0.76
51 Response. J Neurosurg 2015 0.75
52 Antiangiogenesis in recurrent glioblastoma: proof of principle. Neurol Int 2009 0.75
53 Hormonal effect on meningioma growth. World Neurosurg 2011 0.75
54 A common sense approach to radiotherapy planning of glioblastoma multiforme situated in the temporal lobe. Int J Radiat Oncol Biol Phys 2008 0.75
55 The role of advanced MR methods in the diagnosis of cerebral amyloidoma. Amyloid 2009 0.75
56 Cerebellar tumor extension as a late event of long-standing, supratentorial low-grade gliomas: case report. Neurosurgery 2006 0.75
57 Granular cell tumor of the neurohypophysis: case report and review of the literature. Neuro Endocrinol Lett 2013 0.75
58 Trial To Survive: The Impact of Enrollment in Clinical Trials on Survival of Patients with Glioblastoma: 975. Neurosurgery 2009 0.75
59 Calcification in high grade gliomas treated with bevacizumab. J Neurooncol 2015 0.75
60 [The effect of platelet transfusion on traumatic intracranial hemorrhage among patients treated with aspirin]. Harefuah 2012 0.75